Grocer banner

GlaxoSmithKline (GSK)

Share Price:
Down 1,489.40p
Change Today:
-3.80p
Market Cap:
74,724m

Company Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart

1 Day Chart

Last 6 Month

6 Month Chart

Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Latest Director Deals

Traded Action Notifier PriceAmountValue
10-Mar-20 Buy Emma Walmsley 1,569.15p 8 125.53
10-Mar-20 Transfer From Emma Walmsley 0.000p 8 0.00
17-Feb-20 Sell Emma Walmsley 1,661.40p 11,680 194,051.52

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Market Data

Currency UK Pounds
Price 1,489.40p
Change Today -3.80p
52 Week High 1,846.00p
52 Week Low 1,374.60p
Volume 8,284,163
Shares Issued 5,017m
Market Cap 74,724m

Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-20 14-Nov-19
Paid 09-Apr-20 09-Jan-20
Amount 23.00p 19.00p